Evaluation of the use of pertussis monovaccine according to epidemic indications
Okinshevich, E.A.; Kuznetsova, L.S.; Kondrat'eva, A.M.; Buiankina, T.F.; Petrova, A.N.
Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 48: 23-27
1971
ISSN/ISBN: 0372-9311 PMID: 5113368 Document Number: 33944
Document emailed within 1 workday
Related Documents
Corbel, M. J. 1993: Developments in Biological Standardization, volume 73. Pertussis: Evaluation and Research on Acellular Pertussis Vaccines Journal of Medical Microbiology 38(2): 155-156Frühwirth, M.; Wolf, H.; Heininger, H.; Guggenbichler, J.P.; Stehr, E. 1995: Secretory IgA against pertussis toxin and surface structures of Bordetella pertussis in saliva of children with culture proven pertussis Advances in Experimental Medicine and Biology 371b: 777-783
Starosel'skiĭ, D.V.; Ivolgin, A.V.; Chumachenko, M.N. 1971: Indications for determining serum glycoproteins in epidemic hepatitis Vrachebnoe Delo 2: 138-141
Ausloos, G. 1996: Indications et contre-indications de l'approche familiale systémique - Indications and contra-indications of systemic family approach P.R.I.S.M.E. Psychiatrie, Recherche et Intervention en Sante Mentale de l'Enfant 6(4): 534-543
Chodorowska, M. 1999: Humoral reaction to Bordetella pertussis antigens: pertussis toxin, filamentous hemagglutinin and lipopolysaccharide in children with clinical symptoms of whooping cough. II. Occurence and level of B. pertussis antigens in children with suspected whooping cough Medycyna Doswiadczalna i Mikrobiologia 51(3-4): 269-280
Adonajlo, A.; Mazurowska-Magdzik, M.; Pstragowska, W.; Dadak, M. 1975: Effect of infectious diseases on levels of pertussis antibodies in children vaccinated against pertussis Przeglad Epidemiologiczny 29(3): 321-326
Blumberg, D.A.; Pineda, E.; Cherry, J.D.; Caruso, A.; Scott, J.V. 1992: The agglutinin response to whole-cell and acellular pertussis vaccines is Bordetella pertussis--strain dependent American Journal of Diseases of Children 146(10): 1148-1150
Siundiukova, R.A.; Basnak'ian, I.A.; Stukalova, N.V.; Aleksakhina, N.N. 1999: The effect of methylated cyclodextrin on pertussis toxin accumulation in a Bordetella pertussis culture in a bioreactor Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 6: 14-17
Isomura, S.; Suzuki, S.; Sato, Y. 1985: Clinical efficacy of the Japanese acellular pertussis vaccine after intrafamiliar exposure to pertussis patients Developments in Biological Standardization 61: 531-537
Hinman, A.R.; Koplan, J.P. 1984: Pertussis and pertussis vaccine. Reanalysis of benefits, risks, and costs JAMA 251(23): 3109-3113
Gołobów, M.; Kardymowicz, B.; Kudelski, Z.; Rymkiewicz, D.; Sawicki, J. 1986: Evaluation of the toxicity of the pertussis component of the Di-Te-Per vaccine Medycyna Doswiadczalna i Mikrobiologia 38(1): 9-14
Shahdadpuri, R.I.; Nicholson, A.J.; Bedford, D.; O'Flanagan, D. 2004: Pertussis--going, going, but not gone: thirteen year trends in the incidence of pertussis in the Republic of Ireland and North Eastern Health Board Irish Medical Journal 97(2): 44-46
Lau, R.C. 1989: Pertussis (whooping cough) toxin and Bordetella pertussis whole-cell antibody levels in a healthy New Zealand population New Zealand Medical Journal 102(878): 560-562
Schneerson, R.; Robbins, J.B.; Taranger, J.; Lagerård, T.; Trollfors, B. 1997: Examination of similarities between diphtheria and pertussis and their toxoids provide insight into vaccine-induced protection to Bordetella pertussis Developments in Biological Standardization 89: 321-326
Edwards, K.M.; Lawrence, E.; Wright, P.F. 1986: Diphtheria, tetanus, and pertussis vaccine. A comparison of the immune response and adverse reactions to conventional and acellular pertussis components American Journal of Diseases of Children 140(9): 867-871
Chuprinina, R.P.; Alekseeva, I.A.; Ozeretskovskiĭ, N.A. 2006: Prophylaxis of pertussis: development and use of acellular pertussis vaccine Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 2006(1): 99-105
Kambarova, O.I.; Sel'kina, L.E.; Shpiliuk, G.F.; Bodazhkova, K.N.; Dudkina, M.I. 1975: Reactivity and immunogenicity of the Sonne dysentery detergent monovaccine Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 12: 34-38
Rastawicki, W.; Smietańska, K.; Rokosz-Chudziak, N.; Jagielski, M. 2013: Serum immunoglobulin IgG subclass distribution of antibody responses to pertussis toxin and filamentous hemagglutinin of Bordetella pertussis in patients with whooping cough Medycyna Doswiadczalna i Mikrobiologia 65(4): 269-274
Mills, K.H.; Brady, M.; Ryan, E.; Mahon, B.P. 1998: A respiratory challenge model for infection with Bordetella pertussis: application in the assessment of pertussis vaccine potency and in defining the mechanism of protective immunity Developments in Biological Standardization 95: 31-41
Bollag, U.; Matter, L. 1992: Pertussis in clinical practice--critical evaluation of diagnosis and epidemiology Schweizerische Medizinische Wochenschrift 122(41): 1530-1535